0101.KL
BuyFull HouseFLAGTMC Life Sciences Berhad · Healthcare · Malaysia · $193M · Avg Vol: $15K/d
Full House: Strong business, sensible price, market agrees. The rare full house.
Insufficient evidence for a screen-pass. TMC Life Sciences Berhad: clears the 50 floor (Q51/V55/M60) but not the 60 strong bar, and carries no corroborating filing signal (no net insider buying, no active buyback). Absence of evidence is neutral; nothing adverse is known.
ABOUT TMC LIFE SCIENCES BERHAD
Read
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara.
FINANCIAL SUMMARY (MYR)
| Year | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR | TTM |
|---|---|---|---|---|---|---|---|
| Revenue | — | 311.4M | 346.4M | 345.5M | 393.0M | 8.1% | 393.0M |
| EPS (MYR) | 0.02 | 0.02 | 0.02 | 0.00 | 0.01 | -19.5% | 0.01 |
| Shares | — | 1.7B | 1.7B | 1.7B | 1.7B | +0.0% | 1.7B |
| Debt | — | 219.1M | 205.2M | 183.0M | 145.2M | -12.8% | 145.2M |
| Equity | — | 862.0M | 888.0M | 853.0M | 867.2M | 0.2% | — |
| Op CF | — | 54.6M | 74.8M | 22.5M | 57.7M | 1.9% | 57.7M |
| Inv CF | — | -38.9M | -54.2M | -4.6M | 18.3M | — | — |
| Fin CF | — | 2.0M | -29.7M | -64.6M | -43.8M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 0101.KL are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 0101.KL | TMC Life Sciences Berhad(you) | $193M | 73 | Buy |
| 0303.KL | Alpha IVF Group Berhad | $319M | 83 | Strong Buy |
| 0222.KL | Optimax Holdings Berhad | $70M | 88 | Strong Buy |
| 0329.KL | Metro Healthcare Berhad | $51M | 89 | Strong Buy |
| 0363.KL | PMCK Berhad | $54M | 96 | Strong Buy |
| 5878.KL | KPJ Healthcare Berhad | $3.0B | 64 | Hold |
| 5555.KL | Sunway Healthcare Holdings Berhad | $6.1B | 34 | Sell |
| 5225.KL | IHH Healthcare Berhad | $18.1B | 49 | Hold |
| 7081.KL | Pharmaniaga Berhad | $378M | 67 | Buy |
| 5341.KL | LAC Med Berhad | $73M | 71 | Buy |
Peer medians: ROE 11.9% · P/E 24.0x · Gross margin 35.5%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.